NCT03252925View on ClinicalTrials.gov

A Safety and Efficacy Study of NAC in Patients With TA-TMA

PHASE3CompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Thrombotic MicroangiopathiesHematologic Diseases
Interventions
DRUG

N-Acetylcysteine

50mg/Kg.d, oral

DRUG

Placebo Oral Tablet

50mg/Kg.d, oral

Trial Locations (1)

215006

The First affiliated Hospital of SooChow University, Suzhou

All Listed Sponsors
lead

The First Affiliated Hospital of Soochow University

OTHER

NCT03252925 - A Safety and Efficacy Study of NAC in Patients With TA-TMA | Biotech Hunter | Biotech Hunter